CHAIRMAN ROBIN TAYLOR called the Judiciary Committee meeting to order at 1:38 p.m. and announced the presence of Senators Parnell and Ellis. The first order of business before the committee was HB 69. HB 69 ROHYPNOL AS SCHEDULE IV-A DRUG  REPRESENTATIVE AL VEZEY , sponsor of the measure, gave the following overview of the legislation. Flunitrazepam belongs to the Schedule IV class of medications known as benzodiazepines. It came on the market about the time Alaska enacted its Title 11 statutes and did not get incorporated into that title. The drug has shown up on the crime scene during the last two years, and is rapidly becoming the drug of choice for those who wish to commit the heinous crime of date rape. It leaves a victim with no memory of events that occurred shortly after ingestion of the drug for up to two to eight hours and is not detectable by standard urinalysis tests. Flunitrazepam was classified in Schedule IVA because all other benzodiazapines are in that schedule. Number 055 CHAIRMAN TAYLOR asked what felony classification possession of the drug would fall under. REPRESENTATIVE VEZEY answered the controlled substance statutes vary according to how a violation occurs. If a person was caught in possession of less than 25 tablets of flunitrazepam, the offense would be a class A misdemeanor; if more than 25 tablets, a class C felony. If a person attempts to distribute the drug to a minor, the offense would be a class B felony. If the drug is used in the commission of a crime, the offense would be classified as sexual assault in the first degree, an unclassified felony. Number 073 MR. GEORGE TAFT, director of the Scientific Crime Laboratory in Anchorage, testified via teleconference and informed the committee one case involving use of this drug has appeared in Alaska; that case is now pending. The states of Texas and Florida have published numerous articles about the various problems flunitrazepam has created in those states. CHAIRMAN TAYLOR asked Mr. Taft if this drug is used in any form by the medical profession. MR. TAFT was not aware of any valid medical use, and added it is not approved for use in the United States. REPRESENTATIVE VEZEY commented flunitrazepam is used in 64 to 80 countries as a medication for extreme sleep disorders. It is not licensed for manufacture or distribution in the United States. The manufacturer does not intend to get it licensed here because other drugs are prescribed for sleep disorders. However, it is becoming prevalent on the crime scene in the United States because it is readily available in other countries. Number 133 LAUREE HUGONIN , Executive Director of the Alaska Network on Domestic Violence and Sexual Assault, testified in support of HB 69 and submitted written testimony to committee members. SENATOR PARNELL asked Ms. Hugonin if she is familiar with cases involving flunitrazepam other than the one case mentioned by Mr. Taft. MS. HUGONIN said she is familiar with the one case and suspects other unreported cases have occurred. JAYNE ANDREEN , Director of the Council on Domestic Violence and Sexual Assault, stated the Council's support of HB 69 for the reasons stated by previous speakers. SENATOR PARNELL moved SSHB 69 from committee with individual recommendations. There being no objection, the motion carried.